Erin Winstanley, PhD – Associate Professor
School of Pharmacy; Behavioral Medicine & Psychiatry; Rockefeller Neuroscience Institute
Ph.D., Health Policy & Management, The Johns Hopkins Bloomberg School of Public Health (2006); M.A., Sociology, University of Illinois at Chicago
Johns Hopkins School of Medicine, Behavioral Pharmacology Research Unit
Dr. Winstanley’s current research is focused on reducing the morbidity and mortality associated with the opioid epidemic, as well as the use of technology to improve access and quality of behavioral health services.
Dr. Winstanley’s current research projects include 1) analyses of policies related to the opioid epidemic using prescription drug monitoring program (PDMP) data; 2) development of a brief intervention to improve the safe use, storage and disposal of prescription opioids; 3) improving linkage to prevention and treatment services among patients that have experienced a drug overdose; 4) school-based screening, brief intervention and referral to treatment (SBIRT) and 5) dissemination/implementation of evidence-based practices to improve outcomes for patients with opioid use disorders.
Lab Personnel + Collaborators
- Amanda Stover, MPH
- Yifan Zhang, MPH
- Winstanley EL, Zhang Y, Mashni R, Schnee S, Penm J, Boone J, McNamee C, MacKinnon NJ (2018). Mandatory review of a prescription drug monitoring program and impact on opioid and benzodiazepine dispensing. Drug and Alcohol Dependence, 188:169-174.
- Winstanley EL, Stroup-Menge B, Snyder K (2018). The promise of technology-based services for addiction treatment clients residing in nonurban areas. Journal of Studies on Alcohol and Drugs, 79(3): 503-504.
- Winstanley EL, Burtchin M, Zhang Y, Campbell P, Pahl J, Beck S, Bohenek W. (2017) Inpatient experiences with MyChart Bedside. Telemedicine and e-Health, doi: 10.1089/tmj.2016.0132.
- Winstanley EL, Mashni R, Schnee S, Miller N, Mashni S. (2017) The development and feasibility of a pharmacy-delivered opioid intervention in the emergency department. Journal of the American Pharmacists Association; 57(2S):S87-S91.
- Penm J, MacKinnon NJ, Boone J, Ciaccia A, McNamee C, Winstanley EL. (2017) Opioid safety: A case study in Ohio. Journal of the American Pharmacists Association; 57(2S):S148-S153.
- Clark A, Breitenstein S, Martsolf DS, Winstanley EL. (2016) Assessing Fidelity of a Community-Based Opioid Overdose Prevention Program: Modification of the Fidelity Checklist. Journal of Nursing Scholarship; 48 (4): 371-7.
- Winstanley EL, Clark A, Feinberg J, Wilder CM. (2016) Implementation of opioid overdose prevention programs: A case report from Ohio. Substance Abuse; 37(1): 42-6.
- Winstanley EL. (2016) Tangled-Up & Blue: Releasing the Regulatory Chokehold on Take-Home Naloxone. Addiction; 111(4): 583-4.
- Butler MM, Ancona RM, Beauchamp GA, Yamin CK, Winstanley EL, Hart KW, Ruffner AH, Ryan SW, Ryan RJ, Lindsell CJ, Lyons MS. (2016) ED Prescription opioids as an initial exposure preceding addiction. Annals of EmergencyMedicine; 68(2): 202-8.